Kairos Pharma, Ltd. · Brief

Next report

16 days

Nov 16est.Q3 FY26

Expected move

No implied move.

No reported quarters.

Nov 16 report · est.

—

KAPA report session

No linked exposure.

Oct 6haltTrading halt: 11:45 ET, resumed 11:50 ET.Source

Oct 6haltTrading halt: 11:37 ET, resumed 11:42 ET.Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.